Role of Lactic Acid Probiotic Bacteria in IBD

Author(s): Ravichandra Vemuri*, Rohit Gundamaraju, Rajaraman Eri

Journal Name: Current Pharmaceutical Design

Volume 23 , Issue 16 , 2017


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: IBD is considered as one of the major public health concerns worldwide. The pathophysiology and gut microbial alteration during inflammatory bowel disease (IBD) are still not completely understood. Gut microbiota is implicated in most of the gastro-intestinal (GI) diseases including IBD. From the time of gut microbiota establishment and through aging, it undergoes a lot of changes in the composition.

Methods: In a healthy state, the composition of beneficial microbes in the gut is comparatively higher and due to factors such as malnutrition, use of antibiotics and any underlying diseases allow the colonization and invasion of pathogens.

Results: A careful manipulation of gut microbiota during disease conditions such as IBD is required. Probiotics are natural, safe and useful interventions for GI diseases.

Conclusion: Lactic acid probiotic bacteria have shown many beneficial effects in various gastrointestinal and inflammatory disorders. This review focuses on the use of probiotics in IBD and possible mechanism of probiotics in inflammation conditions.

Keywords: Probiotics, IBD, gut microbiota, pathophysiology, gastro-intestinal (GI), antibiotics.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 23
ISSUE: 16
Year: 2017
Published on: 19 June, 2017
Page: [2352 - 2355]
Pages: 4
DOI: 10.2174/1381612823666170207100025
Price: $65

Article Metrics

PDF: 53
HTML: 13
PRC: 1